GMAB
Genmab A/S
Company Overview
| Mkt Cap | $19.28B | Price | $28.61 |
| Volume | 1.57M | Change | -0.21% |
| P/E Ratio | 2.5 | Open | $28.56 |
| Revenue | $21.5B | Prev Close | $28.67 |
| Net Income | $7.8B | 52W Range | $17.24 - $33.65 |
| Div Yield | N/A | Target | $35.85 |
| Overall | 46 | Value | 60 |
| Quality | 42 | Technical | 36 |
No chart data available
Stock Overview
Updated DailyGenmab A/S (GMAB) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $28.61 with a market capitalization of $19.28 billion. The stock is positioned in the upper portion of its trading range, demonstrating below-average quality metrics with a MarketXLS quality score of 42.
Today's trading session shows GMAB with a volume of 1.57 million shares. The stock opened down 0.38% from yesterday's close of $28.67. Current analyst estimates project earnings of $1.78 per share for this year, with next year targeting $1.96.
GMAB demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including ORTH-CA, OTIC, OTLC, OTLK.
Key investment considerations for GMAB include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 25.3%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:10 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GMAB | $28.61 | -0.2% | 1.57M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |